About 3 million people in the United States have glaucoma, and it’s the second leading cause of blindness worldwide, according to the Centers for Disease Control and Prevention. While there is no cure ...

Glaucoma is the term for a group of eye conditions that damage the optic nerve at the back of the eye. Without treatment, it can lead to vision loss and blindness. Glaucoma is not a life threatening ...

Medication, laser, and surgery are all methods of treating glaucoma according to Jonathan Eisengart, MD. Jonathan Eisengart, MD, an ophthalmologist at Cleveland Clinic, explained how different ...

Blindness can be caused by a host of factors including retinal infections, metabolic diseases such as diabetes, age-related conditions such as macular degeneration, or genetic disorders such as ...

SAN FRANCISCO--(BUSINESS WIRE)--Glaucoma Research Foundation, a national non-profit organization dedicated to finding a cure for glaucoma, has launched the third phase of its collaborative research ...

Dr. Olivier answers the question: 'Topical Prostaglandins For Glaucoma?' Aug. 24, 2009— -- Question: What are topical prostaglandins, when are they used to treat glaucoma, and what are the ...

You may notice vision loss and changing glaucoma symptoms if your prescribed medicated eye drops stop working. Your doctor can help test your visual field and determine if you need different drops or ...

SAN FRANCISCO, July 21, 2025 /PRNewswire/ -- The Glaucoma Center of San Francisco is excited to announce the first treatment of a patient in the U.S. with the non-invasive Eyetronic nerve stimulating ...

There are typically no visual changes in the initial stages of glaucoma. As damage occurs to the optic nerve, people may develop blind spots in their peripheral visual field. Some can see halos and ...

Hanna and Mark Gleiberman have committed $20 million to establish the Hanna and Mark Gleiberman Center for Glaucoma Research at UC San Diego. Photo credit: Shannon Henry at Studio Carre Photographie ...

HEIDELBERG, Germany--(BUSINESS WIRE)--Novaliq GmbH, a specialty pharmaceutical company for the development and commercialization of first- and best-in-class ocular therapeutics based on EyeSol ® and ...

The Cleveland Clinic explains that glaucoma, also referred to as the “silent thief of sight,” is a group of eye diseases that gradually damage the optic nerve, typically due to increased pressure ...